Metformin Monotherapy Does Not Decrease AF Risk in Type 2 Diabetes – The Cardiology Advisor
Compared with other noninsulin monotherapies, metformin as an initial treatment for type 2 diabetes (T2D) is not associated with decreased risk for atrial fibrillation (AF). These findings, from a retrospective…